Small cell lung cancer
Conditions
Interventions
Observation group:N/A
Sponsors
Jilin Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Sign informed consent; 2. Age =18 years old; 3. ES-SCLC with histologically confirmed and initially treated (any T, any N, M1a/b/c, or T3-4 that cannot be included in a tolerable radiotherapy schedule due to multiple nodules in the lungs or tumor/nodules too large); 4. The Eastern Cooperative Oncology Group (ECOG) score: 0-2; 5. Have at least one measurable lesion according to RECIST version 1.1; 6. Plan to receive first-line treatment with immunotherapy plus chemotherapy regimen; 7. Provide tumor tissue samples and blood samples.
Exclusion criteria
Exclusion criteria: 1. Mixed SCLC confirmed by histology or cytology; 2. Patients who refuse to receive first-line treatment; 3. A history of other malignant tumors in the past 5 years (cured localized tumors, such as skin base cell carcinoma, skin squamous cell carcinoma, superficial bladder carcinoma, prostate carcinoma in situ, cervical carcinoma in situ, and breast carcinoma in situ were eligible for inclusion).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurable Residual Disease; | — |
Countries
China
Contacts
Public ContactCheng Ying
Jilin Cancer Hospital
Outcome results
None listed